Seeing Is Believing
Processa Pharmaceuticals's activity chart (see below) currently has 21 price targets and 21 ratings on display.
Analysts average stock forecasts to be materialized ratio is 47.78% with an average time for these price targets to be met of 153.4 days.
Most recent stock forecast was given by from HC WAINWRIGHT on 02-Sep-2025. First documented stock forecast 08-Dec-2020.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 13-May-2024
$1
$-0.86 (-46.24%)
$2
1 years 1 months 5 days ago
(02-Sep-2025)
8/9 (88.89%)
$-3.7 (-78.72%)
235
Buy Since 19-Apr-2022
$1000
2 years 10 months 20 days ago
(17-Nov-2023)
0/2 (0%)
$670 (203.03%)
Buy Since 08-Dec-2020
$80
$78.39 (4868.94%)
$300
3 years 6 months 3 days ago
(04-Apr-2023)
2/3 (66.67%)
$-165 (-67.35%)
297
Buy Since 02-Aug-2021
$4000
3 years 6 months 4 days ago
(03-Apr-2023)
0/4 (0%)
$2700 (207.69%)
What is PCSA (Processa Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on PCSA (Processa Pharmaceuticals)?
Which analyst has the current lower performing score on PCSA (Processa Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on PCSA (Processa Pharmaceuticals)?
Which analyst is the currently most bullish on PCSA (Processa Pharmaceuticals)?
Which analyst is the currently most reserved on PCSA (Processa Pharmaceuticals)?